IRINOTECAN MYLAN GENERICS 20 mg/ml concentrato per soluzione per infusione clinical trials

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for resectable colorectal peritoneal metastases: a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).

This study compares two ways to treat bowel cancer that has spread to the lining of the tummy. It looks at whether adding chemotherapy before surgery helps people live longer compared to surgery alone. The aim is to find the best treatment plan.